Back to Search
Start Over
Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma.
- Source :
- Science Translational Medicine; 8/23/2017, Vol. 9 Issue 404, p1-12, 12p
- Publication Year :
- 2017
-
Abstract
- The article focuses on a clinical trial conducted for analyzing therapeutic use of oncolytic virus in hepatocellular carcinoma (HCC) patients. Various topics discussed include its influence on HCC and primary HCC tissues, nonhuman primates, potency of virus, anticancer drug screening and its toleration by nonhuman primates.
- Subjects :
- CLINICAL trials
LIVER cancer patients
LIVER cancer
PRIMATES
ANTINEOPLASTIC agents
Subjects
Details
- Language :
- English
- ISSN :
- 19466234
- Volume :
- 9
- Issue :
- 404
- Database :
- Complementary Index
- Journal :
- Science Translational Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 125274251
- Full Text :
- https://doi.org/10.1126/scitranslmed.aam7996